Logo
x

Search

Subscribe Now

Jiangsu Recbio Technology

Jiangsu Recbio Technology Reports Interim Analysis Data from the Study of REC610 for Shingles Conducted in the Philippines

Jiangsu Recbio Technology Reports Interim Analysis Data from the Study of REC610 for Shingles Conducted in the Philippines

  • December 29, 2023
Jiangsu Recbio Technology Reports P-II Study Results of Two-Component COVID-19 Vaccine ReCOV

Jiangsu Recbio Technology Reports P-II Study Results of Two-Component COVID-19 Vaccine ReCOV

  • December 27, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.